Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001216267 | SCV001388055 | pathogenic | X-linked severe congenital neutropenia; Thrombocytopenia 1; Wiskott-Aldrich syndrome | 2022-08-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg41*) in the WAS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in WAS are known to be pathogenic (PMID: 15284122). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 945596). This variant is also known as 155C>T. This premature translational stop signal has been observed in individual(s) with Wiskott-Aldrich syndrome (PMID: 8528198, 15497008, 21185603, 25862925, 27566838). |
Prevention |
RCV003908449 | SCV004727282 | pathogenic | WAS-related disorder | 2024-01-29 | no assertion criteria provided | clinical testing | The WAS c.121C>T variant is predicted to result in premature protein termination (p.Arg41*). This variant has been reported to be causative for Wiskott-Aldrich syndrome (Kolluri et al. 1995. PubMed ID: 8528198; Gulácsy et al. 2010. PubMed ID: 21185603; Vignesh et al. 2016. PubMed ID: 27566838). This variant has also been reported in individuals with suspected primary immunodeficiency (Platt et al. 2020. PubMed ID: 32888943. Table E2). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in WAS are expected to be pathogenic. This variant is interpreted as pathogenic. |